Skip to content
Subscriber Only
Technology
Prognosis

AstraZeneca Offers a Perch to Cancer High Flier Who Stumbled

  • Hands-on experience helped cement Astra deal for Daiichi drug
  • Baselga jump-started research in Barcelona, then New York
A logo sits on a sign outside AstraZeneca Plc's factory in Macclesfield.
A logo sits on a sign outside AstraZeneca Plc's factory in Macclesfield.Photographer: Paul Thomas/Bloomberg

The second day into Jose Baselga’s tenure as head of AstraZeneca Plc’s cancer research, his new boss called him in to discuss a rival company’s drug.

Under development by Daiichi Sankyo Co., it represented the latest generation of treatments the researcher had tested earlier in his career. The drug could transform the way doctors look at one of the most common forms of breast cancer, Baselga told Astra Chief Executive Officer Pascal Soriot, who was already thinking about a deal.